共 50 条
- [4] Real-world Data of the new JAK Inhibitors Baricitinib, Upadacitinib, and Abrocitinib in Patients with Atopic Dermatitis [J]. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2023, 21 : 111 - 112
- [8] Characterization of disease burden, treatment and comorbidities in a large, real-world cohort of patients with atopic dermatitis: The CorEvitas Atopic Dermatitis Registry [J]. JAAD INTERNATIONAL, 2024, 15 : 127 - 130